These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17562445)

  • 1. Serum VEGF-C is associated with metastatic site in patients with malignant melanoma.
    Vihinen PP; Hilli J; Vuoristo MS; Syrjänen KJ; Kähäri VM; Pyrhönen SO
    Acta Oncol; 2007; 46(5):678-84. PubMed ID: 17562445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
    Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
    Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression.
    Kurschat P; Eming S; Nashan D; Krieg T; Mauch C
    Br J Dermatol; 2007 Apr; 156(4):653-8. PubMed ID: 17263813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumoural expression and circulating level of VEGFR-3 (Flt-4) in metastatic melanoma patients: correlation with clinical parameters and outcome.
    Mouawad R; Spano JP; Comperat E; Capron F; Khayat D
    Eur J Cancer; 2009 May; 45(8):1407-14. PubMed ID: 19157860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
    Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
    J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of vascular endothelial growth factor-C does not predict occult lymph-node metastasis in early oral squamous cell carcinoma.
    Faustino SE; Oliveira DT; Nonogaki S; Landman G; Carvalho AL; Kowalski LP
    Int J Oral Maxillofac Surg; 2008 Apr; 37(4):372-8. PubMed ID: 18295452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating vascular endothelial growth factor in cutaneous malignant melanoma.
    Pelletier F; Bermont L; Puzenat E; Blanc D; Cairey-Remonnay S; Mougin C; Laurent R; Humbert P; Aubin F
    Br J Dermatol; 2005 Apr; 152(4):685-9. PubMed ID: 15840099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy.
    Wimmer I; Meyer JC; Seifert B; Dummer R; Flace A; Burg G
    Cancer Res; 1997 Nov; 57(22):5073-6. PubMed ID: 9371505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
    Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The prognostic role of clinical factors, VEGF, IL-8 and sTNF-R1 in cutaneous melanomas at locoregional stage].
    Ługowska I; Kowalska M; Zdzienicki M; Fuksiewicz M; Kamińska J; Szamotulska K; Rutkowski P
    Pol Merkur Lekarski; 2012 Jan; 32(187):22-7. PubMed ID: 22400175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of serum VEGF in melanoma patients: a pilot study.
    Ascierto PA; Leonardi E; Ottaiano A; Napolitano M; Scala S; Castello G
    Anticancer Res; 2004; 24(6):4255-8. PubMed ID: 15736481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of serum S-100beta and interleukins as tumour markers in advanced melanoma.
    Vuoristo MS; Kellokumpu-Lehtinen P; Laine S; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E
    Melanoma Res; 2000 Jun; 10(3):237-41. PubMed ID: 10890377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
    Yu XM; Lo CY; Lam AK; Leung P; Luk JM
    Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors.
    Del Vecchio M; Mortarini R; Canova S; Di Guardo L; Pimpinelli N; Sertoli MR; Bedognetti D; Queirolo P; Morosini P; Perrone T; Bajetta E; Anichini A
    Clin Cancer Res; 2010 Dec; 16(23):5862-72. PubMed ID: 21030496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
    Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
    Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.
    Bogos K; Renyi-Vamos F; Dobos J; Kenessey I; Tovari J; Timar J; Strausz J; Ostoros G; Klepetko W; Ankersmit HJ; Lang G; Hoda MA; Nierlich P; Dome B
    Clin Cancer Res; 2009 Mar; 15(5):1741-6. PubMed ID: 19240177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab.
    Vihinen PP; Ramadan S; Vuoristo MS; Hernberg M; Tyynelä-Korhonen K; Skyttä T; Koskivuo I; Kellokumpu-Lehtinen PL; Syrjänen K; Pyrhönen S
    Melanoma Res; 2011 Oct; 21(5):431-7. PubMed ID: 21730877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-C in patients with breast cancer.
    Al-Mowallad A; Kirwan C; Byrne G; McDowell G; Li C; Stewart A; Al-Qouzi A; Kumar S
    In Vivo; 2007; 21(3):549-51. PubMed ID: 17591368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor lymphangiogenesis and melanoma metastasis.
    Rinderknecht M; Detmar M
    J Cell Physiol; 2008 Aug; 216(2):347-54. PubMed ID: 18481261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.